2017 annual financial data
Karyopharm Therapeutics 2017 Operating margin
Karyopharm Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was -8,133.21%.
Operating income was -130,538,000 USD and net income was -128,984,000 USD.
Operating cash flow was -73,717,000 USD.
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,605,000 USD
- Operating income
- -130,538,000 USD
- Net income
- -128,984,000 USD
- Operating cash flow
- -73,717,000 USD